TY  - GEN
AU  - Mahadevan,D
AU  - Mita,Monica
AU  - Richards,Donald
AU  - McClay,Edward
AU  - Heist,Rebecca Suk
AU  - Kumar,A
AU  - Sundararajan,S
AU  - Naing,Aung
TI  - Phase I single dose, two-period and two-sequence cross-over trial to evaluate the relative bioavailability of two oral pimasertib formulations in advanced cancer patients
SN  - 1432-0843
PY  - 2017///0613
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Area Under Curve
KW  - Biological Availability
KW  - Capsules
KW  - Cross-Over Studies
KW  - Drug Compounding
KW  - Female
KW  - Humans
KW  - MAP Kinase Signaling System
KW  - drug effects
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Niacinamide
KW  - Protein Kinase Inhibitors
KW  - Tablets
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-017-3258-0
ER  -